Results 101 to 110 of about 177,041 (162)

Regulatory mechanisms of exercise-induced physiological cardiac hypertrophy: progress and prospects. [PDF]

Front Cardiovasc Med
Cheng P, Zhang X, Si Y, Yin Q, Chen L, Ru Q, Chu C, Xiang H, Liao L, Ran H, Zhang Z, Wu Y.   +11 more
europepmc   +1 more source

MicroRNA mediated regulation in early-onset cardiac hypertrophy: Insights from the hypertrophic heart rat model. [PDF]

PLoS One
Sadiq S, Charchar FJ, Sanigorski A, Crowley T, Bookun HR, McClure DN.   +5 more
europepmc   +1 more source

The effect of cuproptosis-related gene Atox1 on cardiac hypertrophy in heart failure was investigated based on bioinformatics analysis. [PDF]

Sci Rep
Zhou H, Yang M, Jin H, Ye Z.
europepmc   +1 more source

Epistasis regulates genetic control of cardiac hypertrophy. [PDF]

Nat Cardiovasc Res
Wang Q, Tang TM, Youlton M, Weldy CS, Kenney AM, Ronen O, Hughes JW, Chin ET, Sutton SC, Agarwal A, Li X, Behr M, Kumbier K, Moravec CS, Tang WHW, Margulies KB, Cappola TP, Butte AJ, Arnaout R, Brown JB, Priest JR, Parikh VN, Yu B, Ashley EA.   +23 more
europepmc   +1 more source

Case Report: Novel GLA mutation in a Chinese female with renal-predominant Fabry disease and cardiac hypertrophy. [PDF]

Front Genet
Li L, Chang T, Li X, Hao Y, Deng M, Li Y.   +5 more
europepmc   +1 more source

Cathepsin B in human peripheral blood lymphocytes as a peripheral biomarker for cardiac hypertrophy. [PDF]

Sci Rep
Feng D, Li C, Gao W, Sui Y, Zhao S, Wang Y, Zhang G, Dong Y, Wang J.   +8 more
europepmc   +1 more source

Unlocking Hopeaphenol: A Potent Ally Against Cardiac Hypertrophy via AMPK Activation. [PDF]

Nutrients
Chen J, Wang M, Zhang Z, Fang C, Zhuang H, Zhao J, Wang T, Wang J, Li C, Fang C.   +9 more
europepmc   +1 more source

ATF3 overexpression is associated with cardiac hypertrophy and electrical dysfunction accompanied by enhanced cardiac cell proliferation in zebrafish. [PDF]

Sci Rep
Kim E, Kim J, Moon HY, Kim JY, Jeong MH, Kim GY, Lee SH, Kim CH, Kim JW, Kim WH.   +9 more
europepmc   +1 more source

20(S)-protopanaxatriol ameliorates cardiac hypertrophy by activating the AMPK/PGC-1α/PPARγ signaling pathway. [PDF]

J Ginseng Res
Yan X, Zheng H, Ye J, Zhang D, Lv R, Yang L, Lai Q, Ding L, Wang Z.   +8 more
europepmc   +1 more source

SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy

Circulation, 2017
Background: Pathological cardiac hypertrophy induced by stresses such as aging and neurohumoral activation is an independent risk factor for heart failure and is considered a target for the treatment of heart failure.
Xiaoqiang Tang, De-Long Hao, Zhu-Qin Zhang   +2 more
exaly   +2 more sources